When patient safety, regulatory approval and real-world effectiveness are on the line, AI can't act autonomously.
TriNetX® and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced a strategic collaboration to support Regeneron's ...
Constant leadership changes and erratic decision-making have left the biopharmaceutical industry feeling its chief regulator ...
Aptar Digital Health Enable Injections Inc. enFuse Digital Companion Solution Through this partnership, Aptar Digital Health ...
The Trump administration dropped its fiscal 2027 budget request Friday, and the massive document release includes some ...
As pharmaceutical companies lean more heavily on A.I. to accelerate drug discovery, model biological interactions and ...
Samsung Bioepis said Wednesday it has launched a companywide artificial intelligence training program to build AI expertise ...
The Hechinger Report on MSN
Trump squeezed Brown U. for $50 million in job training. Here’s who gets the money
CRANSTON, R.I. — Before he landed in prison three years ago for selling drugs, Joe worked on and off as a construction laborer. In his free time, he’d do little projects around the house, his youngest ...
7d
Phase II Clinical Trial of Monkeypox Treatment by NV-387 to Commence Soon, Announces NanoViricides
SHELTON, CT / ACCESS Newswire / April 1, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company") today ...
Clinical trials are the engine of modern cancer care, transforming scientific discoveries into new treatments that can save ...
A high burden of infectious diseases coexists with a rapid rise in non-communicable diseases such as diabetes, cancer, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results